Form 10
Your Form 10 filing indicates your intention “to file an election to be regulated as a business development company …” Based on your EDGAR filing history you have not filed a Form N-6F or a Form N-54A. Briefly explain your intentions with respect to the filing of these forms.
Transaction referenced in your response to comment 2 of the First Response Letter, please provide a timeline of the following dates:Read in the reply
•
The date on which the Fund was incorporated;
March 26, 2018.
The date on which negotiations began;
Approximately the first week of August 2018 for the Syndicated Warehouse; approximately the end of May 2018 for the Middle Market Warehouse.
The date on which the Warehouse Transaction was signed and agreed to;
August 21, 2018 for the Syndicated Warehouse; September 10, 2018 for the Middle Market Warehouse.
The date on which the Fund registered as a BDCRest of the answer
under the Investment Company Act of 1940 Act, as amended (the
“1940 Act”); and
October 26, 2018.
The date on which the Fund is required or has the option to make purchases under the Warehouse
Transaction.
For the Middle Market Warehouse, the Fund has the option to purchase assets from the warehouse when it chooses (so long as before September 10, 2019) and, subject to a fundraising contingency, all qualifying assets must be purchased by September 10, 2019 (as may be extended if agreed by the warehouse provider or accelerated in the case of an event of default).
For the Syndicated Warehouse, the Fund or its affiliate has a conditional obligation to execute a takeout within four months of the date on which the Fund raises equity capital of at least $200,000,000 (which has to be within six months of August 21, 2018).
In addition, please tell us who negotiated and approved the Warehouse Transactions on behalf of the Fund and what their relationship was or is to the Fund.
Please confirm whether the Warehouse Transactions were approved by a 1940 Act-compliant board and/or process.
The Warehouse Transactions were negotiated by the Fund’s Adviser on behalf of the Fund. The Warehouse Transactions were unanimously approved by the Fund’s board of directors, which include (and included at the time of approval) a majority of directors that are not interested persons as would be required by Section 56(a) of the 1940 Act.
On page three you discuss the possibility that you may acquire investments, including from an affiliate, “at cost to the warehousing party plus carrying charges, notwithstanding that the fair market value of such investments may have declined below or increased above such cost at the time of transfer.” You further state that “[a]ny such agreement would be made at or prior to the warehousing party’s acquisition, suchRest of the question
that the parties would not know at the time of the agreement whether the investment will appreciate or depreciate prior to the Fund’s acquisition …” With a view to disclosure, please explain: How the types of warehousing transactions you will use work and are structured, including who selects the investments that end up in the portfolio, what is included in “carrying charges,” and other material terms of the arrangement; How your obligation to purchase investments, including potential losses thereon, is accounted for and otherwise reflected in NAV. In addition, please explain how these obligations are treated for purposes of complying with Section 61 of the Investment Company Act of 1940 (1940 Act); Whether you will treat your warehouse agreements as an off-balance sheet obligation for disclosure purposes pursuant to Item 303(a)(4) of Regulation S-K; and, With respect to purchases involving affiliates, please explain how the transactions are structured to comply with Section 57 of the 1940 Act. In addition, please add disclosure addressing the potential for investor dilution if you engage in warehousing transactions under these terms.
We note that portions of your response to comment 2 of the First Response Letter hinge upon whether the fundraising contingency is met. Under certain circumstances, you may need to evaluate your disclosure obligation based on the probability of the occurrence and not simply whether the event has occurred. Please acknowledge and, if warranted, revise your existing and future disclosures.Read in the reply
The Fund acknowledges the comment and will update future disclosures as warranted.
Starting on page three you use footnotes as part of your disclosure. In some instances the footnotes impede the disclosure. Where possible, please remove these footnotes and include necessary context in the relevant paragraph.
With respect to the Forward Purchase Agreement with Warehouse Investment Limited filed as Exhibit 10.6 to the Amended Registration Statement, please:Read in the reply
Advise whether every asset purchased by Warehouse Investment Limited that the Fund agrees is a qualifying asset must be presented by Warehouse Investment Limited to the Fund for purchase;
Confirmed.Rest of the answer
The Fund must be presented with, and in fact has the obligation, subject to a fundraising contingency, to purchase (prior to September 10, 2019 under the Forward Purchase Agreement), all qualifying assets held by Warehouse Investment Limited.
Tell us who the “Facility Provider” referenced in Section 2.1 is and any obligation you owe to them under the agreement or otherwise; and
The Facility Provider is Warehousing Investment
Limited, the same entity that is the Seller under the Forward Purchase Agreement.
Tell us more about the “broken deal” expenses referenced in Section 3.4, including how and when they would be reflected in NAV.
Section 3.4 provides that the Fund may, at its option, request the Seller under the Forward Purchase Agreement to sell a qualifying asset (i.e., an asset the Fund is obligated, subject to a fundraising contingency, to purchase under the Forward Purchase Agreement) to parties other than the Fund. If the
Fund gives such a direction, the Fund agrees to pay the difference between the price the Fund would have had to pay to purchase such asset from the Seller under the Forward Purchase Agreement and the price the Seller actually obtains in the sale to another party, which under Section 3.4 is referred to as a “broken deal” expense. Any broken deal expense would be reflected as a reduction in the Fund’s NAV when such expense is paid to the extent the expense was greater than the liability, if any, for any difference in the market value of the applicable asset and the forward purchase price already reflected in the Fund’s NAV.
On page three you state you will employ “a defensive investment approach … generally lending on a basis of 3.5 times to 5.5 times the borrower’s earnings before interest, taxes, depreciation and amortization and at loan to value ratios of 50%-65% …” Please revise your disclosure to clarify what lending on a basis of 3.5 times to 5.5 times borrower EBITDA means.Rest of the question
In addition, please clarify how EBIDTA is calculated – for example, is it based on historical or projected numbers, does it include add-backs, etc. Also, please clarify how “value” is determined for purposes of calculating your loan to value ratios.
With respect to the Purchase and Sale Agreement with Sente Master Fund, L.P. filed as Exhibit 10.7 to the Amended Registration Statement, please:Read in the reply
Explain how your characterization of the agreement in your response to comment 2 of the First Response Letter is accurate when Section 1(a) of the agreement requires the Fund to execute a “GSO Takeout” or arrange for another entity to do so; and,
The previous characterization of the Purchase and Sale Agreement in response to comment 2 of the First Response Letter is consistent with
Section 1(a) of the agreement, which conditionally requires theRest of the answer
Fund to execute or arrange the execution of a GSO Takeout in the form of a purchase of the equity interests of the warehouse entity from a third party. Section 1(a) defines
“GSO Takeout” by reference to the “Credit Agreement,” which defines “GSO Takeout” to include, in addition to such purchase of equity interests, a sale of all of the portfolio assets by the warehouse adviser, a refinancing or a refinancing through a CLO transaction. Importantly, a GSO takeout event does not require the Fund to be the entity that effects a GSO Takeout. Rather the entity effecting a GSO Takeout can be the Fund or another GSO entity.
With respect to the Fund’s assumption of Sente Master Fund, L.P.’s obligations under each of the
“Credit Agreement” and the “Preference Share Subscription Agreement,” briefly explain what these obligations are and how they would be reflected in disclosure, when applicable.
Sente Master Fund, L.P. (“Sente”) has entered into a credit agreement, the salient terms of which are described on page 20 of the Amended Registration Statement. If the Fund were to acquire the Sente warehouse vehicle and such credit facility were to remain outstanding, it would become an obligation of the Fund’s subsidiary and would be consolidated into the
Fund’s financial statements (along with the assets of the warehouse vehicle).
Sente is the preferred investor. The preferred investor has the obligation to subscribe for the preference shares of the warehouse vehicle (Macomb Park) by making capital contributions. Such capital contributions can be used for the warehouse vehicle to acquire assets, pay down the warehouse lenders or cure certain overcollateralization breaches.
The disclosure on page four states that, “[s]ubject to the limitations of the 1940 Act, we may invest in loans of other securities, the proceeds of which may refinance or otherwise repay debt or securities of companies whose debt is owned by other GSO funds.” Please explain to us what sorts of investments are contemplated by this statement and how they can be made consistent with the limitations contained in theRest of the question
1940 Act.
Please disclose additional accounting information relating to the Warehouse Transactions. Will these be accounted for as derivatives pursuant to FASB Accounting Standards Codification Topic 815, particularly for the Syndicated Warehouse, where you note on page 20 of the Amended Registration Statement there are 64 loans currently held? Will this asset be accounted for as an equity interest in a CLO or will your financial statements reflect the underlying loans as assets?Read in the reply
The
Fund’s right under the Syndicated Warehouse would meet the definition of a derivative under ASC 815.Rest of the answer
Upon the exercise of the right to acquire the equity interest, which the Fund currently intends to exercise prior to December 31,
2018, the Fund will consolidate the Syndicated Warehouse and include the underlying loans as assets in its consolidated financial statements.
With respect to the Middle Market Warehouse, the Fund has a forward purchase obligation on the underlying securities. However, since the
Forward Purchase Agreement requires physical settlement and the underlying securities are not readily convertible to cash, the forward purchase obligation does not meet the definition of a derivative under ASC 815. The Fund will record the forward purchase obligation at fair value as the difference between (1) the current purchase price the Fund would be obligated to pay to purchase each asset under the Forward Purchase Agreement and (2) the current market value of each such asset within assets or liabilities on the Fund’s Statement of Net Assets, depending on the mark-to-market position on any given measurement date.
On page 15 under Viable Exit Strategy, you disclosure that, “[i]n addition to payments of principal and interest, we expect the primary methods for the strategy to realize returns on our investment include refinancings, sales of portfolio companies, and in some cases initial public offering and secondary offering.Rest of the question
Please clarify whether the loans you will typically make will be amortizing or not; if not, please consider the need for additional disclosure about the assumptions and risks. It is unclear for example, how changes in the credit markets, economy, and other factors impact the viability of your exit strategies, particularly for investments at the lower end of your investment range. Please revise or advise as appropriate.
Will the Warehouse Transaction vehicles be consolidated?Read in the reply
If the equity of the Syndicated Loan Warehouse vehicle is acquired by the Fund it will be consolidated. The Fund will not acquire the Middle
Market Warehouse vehicle, but will acquire the assets from that vehicle, which assets will be included in the Fund’s financial statements.
Supplementally tell us what sorts of information is typically provided under “flash reporting” and how it impacts your NAV calculations.
Is the Fund subject to recourse from the credit facility used by the Syndicated Warehouse?Read in the reply
No. The credit facility is only recourse to the Syndicated Warehouse vehicle.
Please clarify the meaning of the statement on page 18 that, “[w]hen, in order to maximize our recovery, GSO is forced to take positions inconsistent with the company’s shareholders, GSO expects to act quickly to enforce its rights.”
We note your response to comment 5 of the First Response Letter and request additional clarification. As you know, one of the policy concerns expressed in the 1940 Act relates to the potential to use one fund’s assets to prop up the assets or positions of another fund. This concern is expressed in Sections 1, 17 and 57 of the 1940 Act, as well as our standard co-investment orders.Read in the replyRest of the answer
Please provide further clarification of how the types of transactions proposed in your response are consistent with these items.
The Fund acknowledges the Staff’s concern, but respectfully submits that the transactions described in comment 5 of the First Response
Letter would be consistent with the requirements of the 1940 Act. The Fund understands that principal and joint transactions involving an investment company or business development company and its affiliates are generally prohibited, with limited exceptions. In the scenario contemplated in the referenced disclosure, two separate transactions are being conducted (a repayment transaction and a new loan transaction), both transactions are conducted with a third party and neither transaction results in a joint or principal transaction between the Fund and any of its affiliates. In other circumstances, such as where an affiliate of the Fund controls the third party, transactions of this sort may involve a joint or principal transaction, in which case the Fund and/or its affiliates would not be permitted to participate in the transaction, which is why the relevant disclosure is qualified by “[s]ubject to the limitations of the 1940 Act.”
Please clarify what you mean by “fulcrum security” as used on page 19.
We note your response to comment 11 of the First Response Letter and request further information. With respect to your response, it appears you only use quarter-end valuations unless there is information suggesting the valuation of an asset has changed due to a material event. It appears to us that portfolio NAV is a composite and a number of small valuation changes in individual investments may be material to NAV as a whole, even when no individual material event has occurred at an investment.Read in the replyRest of the answer
Please clarify how your valuation policy addresses this or otherwise explain.
The Fund acknowledges the Staff’s concern. As noted in the Fund’s disclosure
(e.g., “As required by the 1940 Act, a significant portion of our investment portfolio is and will be recorded at fair value as determined in good faith by our Board of Trustees and, as a result, there is and will be uncertainty as to the value of our portfolio investments”), the fair valuation of illiquid securities is subject to significant uncertainties. The Fund’s policy with respect to illiquid assets is to update a quarterly valuation for any material events and the Fund would do so even if the material event had a relatively small impact on the valuation of the applicable investment. In the absence of a material market event or material information about the issuer of the security, the Fund will not have any basis on which to update the valuation of the security. Access to new immaterial information about the investment would not provide a clear basis on which to update a fair valuation. However, the Fund recognizes that significant macroeconomic or industry-wide market events since the prior quarter could have an impact on the value of many of the Fund’s securities, which could result in material change in the Fund’s NAV (even if the valuation of individual securities does not change materially). The Fund confirms that it will consider such events when determining the Fund’s NAV.
On page 22 you disclose that you “intend to conduct repurchase offers … on a quarterly basis at a price per share expected to reflect net asset value per share.” Please clarify what date will be used to calculate the NAV investors will be receive in a repurchase offer.
Letter. Your disclosure references “any or all” of your assets while your response appears to be limited to assets pledged as collateral. Please clarify, as appropriate.Read in the reply
The Fund confirms that the analysis described in its response to comment 16 of the First Response Letter applies equally to unsecured borrowings and that the reference to ‘pledged’ assets was incidental. Unsecured borrowers can also seek judgments to enforce their rights by means that include compelling the liquidation of the defaulting borrower’s assets.
The disclosure on page 23 discussing the offering price following the initial drawdown date includes a parenthetical “taking into account any investment valuation adjustments from the last quarterly valuation date in accordance with the Fund’s valuation policy, subject to certain adjustments.” Please confirm your understanding of Section 23(b) of the 1940 Act and explain how the NAV used at the time of sale willRest of the question
comply with Section 23(b).
No numbered answer found in the reply. Read the reply ↗
You currently present over 25 pages of risk factor disclosure. Some of the risk factors are lengthy, detailed, and complex. Others are generic and would apply to any issuer. We are concerned that the length and complexity of the risk disclosure may distract investors from other essential information contained in your prospectus. Please review the risk factors to ensure it is clear and concise and revise as necessary.
No numbered answer found in the reply. Read the reply ↗
The disclosure on page 36 indicates the Advisory Agreement “has been approved,” and “will have termination provisions that allow the parties to terminate the agreement.” Disclosure later in your document suggests the Advisory Agreement has not been approved. See, e.g., page 72 (“We expect to enter into …”). Please revise as necessary.
No numbered answer found in the reply. Read the reply ↗
The disclosure on page 45 suggests you may create a CLO vehicle. Please clarify who will manage the CLO vehicle and any compensation they may receive for structuring and/or managing the vehicle.
No numbered answer found in the reply. Read the reply ↗
The disclosure on page 56 and elsewhere describing your co-investment relief includes a statement that “[n]either the adviser nor its affiliates will be obligated to offer us the right to participate in any transactions originated by them.” Please reconcile this statement to the conditions contained within your exemptive application.
No numbered answer found in the reply. Read the reply ↗
On page 58 you state that, in the event you default under a credit facility, “the agent for the lenders under such borrowing facility could assume control of the disposition of any or all of our assets, including the selection of such assets to be disposed and the timing of such disposition …” Please explain to us the circumstances covered by this statement and how permitting the lending agent this level of controlRest of the question
would be consistent with Section 15 of the 1940 Act and the board and adviser’s fiduciary duties.
No numbered answer found in the reply. Read the reply ↗
We note the page 58 reference to “limitations on how borrowed funds may be used” including restrictions based on geography, industry, loan size, payment frequency, and the like. Please confirm that any material restrictions in your credit agreements impacting investment flexibility will be described in disclosure once known.
No numbered answer found in the reply. Read the reply ↗
The disclosure here and elsewhere indicates that certain costs and expenses of the administrator and adviser will be allocated to you. In an appropriate location, please explain the allocation methodologies that will be used to allocate these costs and expenses.
No numbered answer found in the reply. Read the reply ↗
Please confirm the disclosure on page 97 under Amendment of the Declaration of Trust; No Approval by Shareholders is not designed to limit shareholder voting rights under the 1940 Act, including Section 58.
No numbered answer found in the reply. Read the reply ↗
We note that you have not filed required exhibits. Please note that we review and frequently comment upon these exhibits and plan accordingly.
No numbered answer found in the reply. Read the reply ↗